This provider's $70.1M in total Medicare payments ranks in the 99th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 377% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 85% in 2018
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $257.23 | $69.38 | 3.71x | $187.85 | $2.1M | 29.9K | 22 |
| 2015 | $321.93 | $66.63 | 4.83x | $255.30 | $2.4M | 36.7K | 28 |
| 2016 | $275.71 | $75.57 | 3.65x | $200.14 | $3.5M | 46.8K | 29 |
| 2017 | $461.02 | $76.69 | 6.01x | $384.33 | $4.2M | 55.4K | 34 |
| 2018 | $526.16 | $90.95 | 5.79x | $435.21 | $7.8M | 86.2K | 54 |
| 2019 | $638.90 | $114.36 | 5.59x | $524.54 | $9.9M | 86.2K | 65 |
| 2020 | $455.31 | $108.22 | 4.21x | $347.09 | $9.7M | 89.6K | 57 |
| 2021 | $260.46 | $69.37 | 3.75x | $191.09 | $10.6M | 153.0K | 57 |
| 2022 | $400.76 | $84.82 | 4.72x | $315.94 | $9.9M | 116.3K | 59 |
| 2023 | $640.17 | $114.89 | 5.57x | $525.28 | $9.9M | 86.1K | 57 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 88377 | Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | 39.0K | $10.8M | $277.62 | 6.22x |
| 81455 | Targeted genomic sequence analysis panel of dna or combine dna and rna of 51 or greater genes associated with blood and lymphatic system disorders | 3.5K | $10.1M | $2.9K | 5.08x |
| 88185 | Flow cytometry technique for dna or cell analysis, each additional marker | 294.8K | $8.6M | $29.25 | 5.51x |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 87.1K | $7.0M | $80.83 | 1.53x |
| 81408 | Molecular pathology procedure level 9 | 2.6K | $5.0M | $2.0K | 4.55x |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | 37.4K | $2.6M | $68.81 | 6.04x |
| 81403 | Molecular pathology procedure level 4 | 10.0K | $1.7M | $173.60 | 5.12x |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | 28.7K | $1.6M | $56.61 | 6.14x |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 63.3K | $1.6M | $24.91 | 1.00x |
| 88237 | Tissue culture for tumor disorders of bone marrow and blood cells | 9.3K | $1.4M | $153.98 | 4.42x |
| 88189 | Flow cytometry technique for dna or cell analysis, 16 or more markers | 17.3K | $1.4M | $78.83 | 5.67x |
| 88264 | Chromosome analysis for genetic defects, analyze 20-25 cells | 8.8K | $1.4M | $153.38 | 4.41x |
| 81175 | Gene analysis (additional sex combs like 1, transcriptional regulator) full sequence analysis | 1.5K | $1.0M | $673.55 | 5.09x |
| 88184 | Flow cytometry technique for dna or cell analysis, first marker | 13.5K | $899.9K | $66.59 | 5.81x |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | 17.7K | $873.8K | $49.34 | 5.92x |
| 88368 | Microscopic genetic analysis of tissue, manual, initial procedure | 8.9K | $793.9K | $89.03 | 6.27x |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | 8.9K | $685.9K | $77.17 | 6.00x |
| 81405 | Molecular pathology procedure level 6 | 2.3K | $675.4K | $289.23 | 4.55x |
| 85097 | Bone marrow, smear interpretation | 8.1K | $572.2K | $70.22 | 5.80x |
| 81406 | Molecular pathology procedure level 7 | 1.1K | $516.6K | $466.70 | 4.74x |
This provider submits charges 4.86 times higher than what Medicare actually pays.
A markup ratio of 4.86x means for every $100 Medicare pays, this provider initially charges $486. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in NJ for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Laboratory Corporation Of America Holdings | Raritan, NJ | $1.2B | ⚠️ Flagged |
| Quest Diagnostics Incorporated | Clifton, NJ | $927.2M | ⚠️ Flagged |
| Bioreference Health, Llc | Elmwood Park, NJ | $841.0M | ⚠️ Flagged |
| Accu Reference Medical Lab, Llc | Linden, NJ | $204.9M | ⚠️ Flagged |
| Aculabs Inc | East Brunswick, NJ | $91.5M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data